Saluda Medical, (ASX:SLD) — Material Events
ASX:SLD · 6 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
Saluda Medical Secures FDA Nod for CAP24 Paddle Lead, Expanding US SCS Market AccessMedium
Saluda Medical gains FDA approval for CAP24 surgical paddle lead, expanding U.S. market reach
30 June 2026
·Regulatory Approval
·85
Saluda Medical Posts 28% Revenue Growth but Faces Going Concern QuestionsMedium
Saluda Medical FY26 revenue beats guidance with strong US and international growth; FDA approves CAP24 paddle lead; FY27 guidance signals improved operating leverage
28 Aug 2026
·Full Year Results
·85
Saluda Medical Secures CE Approval for EVA™ Technology, Expands Market ReachMedium
Saluda Medical gains European CE approval for EVA™ Sensing Technology, expanding commercial rollout
22 Dec 2025
·Regulatory Approval Announcement
·85
No articles in this tier for the last 12 months.
Market Mentions
5
- appeared in market wrap coverage
These are market wrap articles where Saluda Medical, (ASX:SLD) was mentioned. They reflect broader market coverage, not company-specific announcements.
Healthcare Wrap - Week 35 (24 Aug -> 28 Aug) 2026
29 Aug 2026
Market Wrap - Week 31 (27 July -> 31 July) 2026
1 Aug 2026
Healthcare Wrap - Week 31 (27 July -> 31 July) 2026
1 Aug 2026
Healthcare Wrap - Week 27 (29 June -> 3 July) 2026
4 July 2026
Healthcare Wrap - Week 5 (26 Jan -> 30 Jan) 2026
31 Jan 2026